Format

Send to

Choose Destination
J Manag Care Spec Pharm. 2019 Dec;25(12):1306-1308. doi: 10.18553/jmcp.2019.25.12.1306.

Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts.

Author information

1
Prime Therapeutics, Eagan, Minnesota.

Abstract

No funding supported the writing of this commentary. The authors are employed by Prime Therapeutics, a pharmacy benefits management company.

PMID:
31778615
DOI:
10.18553/jmcp.2019.25.12.1306
Free full text

Supplemental Content

Full text links

Icon for Academy of Managed Care Pharmacy
Loading ...
Support Center